Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-02-03 @ 7:23 AM
Study NCT ID:
NCT03674866
Status:
COMPLETED
Last Update Posted:
2019-12-06
First Post:
2018-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-05
First Submit QC Date:
None
Study First Post Date:
2018-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-05
Last Update Post Date:
2019-12-06
Last Update Post Date Type:
ACTUAL